Manufacturer knows that thalidomide causes "birth defects" six months before pulling it from the market.
Date: 1961
The British pharmaceutical company Grünenthal manufactures thalidomide, a drug widely prescribed to women as a cure for morning sickness between 1958 and 1961. The company knows for six months before they discontinue its production and sale that thalidomide causes serious "birth defects" and the deaths of fetuses.